Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Trial of Weekly Paclitaxel in Combination With Bavituximab in Patients With Her-2 Negative Metastatic Breast Cancer

NCT01288261 is registered in ClinicalTrials.gov with University of Arizona as lead sponsor.

NCT NCT01288261
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01288261 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Trial of Weekly Paclitaxel in Combination With Bavituximab in Patients With Her-2 Negative Metastatic Breast Cancer
Lead sponsor
University of Arizona
Phase
Phase 1
Overall status
Completed
Start date
January 31, 2011
Completion date
July 31, 2015
Enrollment
14 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

human epidermal growth factor 2 negative carcinoma of breast, male breast cancer, recurrent breast cancer, stage iiic breast cancer, stage iv breast cancer